SwitzerlandSwiss EPFL Develops Brain Chip for Mood and Anxiety Disorders
Researchers at EPFL in Switzerland have developed an implantable brain chip called 'LogSync' to treat mood and anxiety disorders by monitoring and stimulating brain communication.
Background
Mental health disorders are a growing global concern, impacting millions worldwide. Research into advanced neurological treatments, including brain-computer interfaces, is an active field. Switzerland is a hub for medical research and technological innovation.
Quorum · collective opinions
Swiss EPFL Develops Brain Chip for Mood and Anxiety Disorders
First report 16h agoLast update 15h ago1 takes 1
novel treatment developmentneutralShow 3 posts
started 16h ago•Last update 15h ago
Reporting on the development of a new brain chip technology for treating mental health conditions.
iWitness comments
No comments yet — be the first to weigh in.